Visual acuity suppression from Gaboxadol

Visual acuity suppression is experienced as a noticeable decrease in the perceived sharpness and resolution of vision. The world appears softer, less defined, and slightly blurry, as though one's visual system has been turned slightly out of focus. Text — particularly small text — becomes difficult or impossible to read. Fine textures blur into indistinct patches, distant objects lose their detail, and the overall visual scene acquires a dreamy, hazy quality. The effect can range from a mild softening that is more atmospheric than impairing to a significant blurring that meaningfully interferes with visual tasks.

At threshold levels, visual acuity suppression presents as a subtle softness to the visual field — a sense that things are not quite as sharp as they should be, noticeable mainly when trying to read small text or discern fine details. At moderate intensities, the blurring becomes functionally significant: reading becomes difficult, facial details become indistinct at moderate distances, and navigating unfamiliar environments requires more effort. At high intensities, acuity suppression can be profound — the visual field becomes extremely blurry and indistinct, with only large, high-contrast shapes remaining clearly visible.

The effect can manifest in several ways. Uniform blurring affects the entire visual field equally, as though the eyes have been defocused.Central blurring specifically affects the foveal (central) vision while leaving peripheral vision relatively intact — the opposite of normal visual processing.Near-field suppression makes it difficult to focus on close objects while distance vision remains relatively clear.Distance suppression blurs distant objects while near-field vision is less affected. The specific pattern depends on the substance and mechanism involved. Additionally, visual acuity suppression can fluctuate — clarity may come and go in waves, with moments of surprising sharpness interspersed with periods of blurriness.

Multiple mechanisms can produce visual acuity suppression depending on the substance class. Substances that cause pupil dilation (mydriasis) increase optical aberrations, physically reducing the sharpness of the retinal image. Drugs that affect accommodation (the eye's focusing mechanism) — including anticholinergics, alcohol, and some dissociatives — directly impair optical focusing. Centrally, substances that reduce cortical excitability or impair neural processing speed — including alcohol, benzodiazepines, opioids, and cannabis — can reduce the brain's ability to extract fine detail from visual input. Some substances impair acuity through multiple simultaneous mechanisms.

Visual acuity suppression is commonly produced by alcohol, benzodiazepines, opioids, and other CNS depressants. Anticholinergic deliriants like diphenhydramine and scopolamine produce significant acuity suppression through both mydriasis and impaired accommodation. Cannabis frequently produces mild acuity suppression. Dissociatives such as ketamine and DXM reduce visual acuity, particularly at higher doses. Psychedelics can produce acuity suppression at high doses, though they more commonly enhance acuity at low to moderate doses. MDMA may reduce acuity through mydriasis despite enhancing visual engagement.

Visual acuity suppression is not directly dangerous but has significant functional implications. Impaired visual acuity makes it unsafe to drive, operate machinery, or navigate unfamiliar or hazardous environments. The inability to read text can prevent users from accessing information (including harm-reduction resources, dosage information, or emergency contacts) when they might need it most. If visual blurring is accompanied by other concerning symptoms such as severe headache, eye pain, or loss of visual field, medical attention should be sought, as these could indicate elevated intraocular pressure or other serious conditions.